Home
Glenmark Pharmaceuticals Ltd 52 Week Low

Glenmark Pharmaceuticals Ltd
NSE: GLENMARK
YEARLOW
Key Highlights
- The 52 Week Low of Glenmark Pharmaceuticals Ltd is ₹ 958 as of 01 Apr 25 .
Company Fundamentals for Glenmark Pharmaceuticals Ltd
Market Price of Glenmark Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
01 Apr 2025 | 1508.75 |
28 Mar 2025 | 1540.05 |
27 Mar 2025 | 1520.75 |
26 Mar 2025 | 1464.1 |
25 Mar 2025 | 1480.2 |
24 Mar 2025 | 1493.1 |
21 Mar 2025 | 1511.45 |
20 Mar 2025 | 1478.15 |
19 Mar 2025 | 1486.55 |
18 Mar 2025 | 1457.85 |
Asset Value vs Market Value of Glenmark Pharmaceuticals Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Historical Revenue of Glenmark Pharmaceuticals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Glenmark Pharmaceuticals Ltd
Historical Net Profit of Glenmark Pharmaceuticals Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Glenmark Pharmaceuticals Ltd
Glenmark Pharmaceuticals Ltd News Hub
Glenmark Pharmaceuticals Ltd spurts 2.5%, rises for fifth straight session
Glenmark Pharmaceuticals Ltd gained for a fifth straight session today. The stock is quoting at Rs 1
Read more
21 Aug 24
Glenmark Pharmaceuticals Ltd soars 4.33%, rises for third straight session
Glenmark Pharmaceuticals Ltd rose for a third straight session today. The stock is quoting at Rs 163
Read more
19 Aug 24
Glenmark Pharma gains after American subsidiary launches Olopatadine generic
The solution is the generic version of 'Pataday Twice Daily Relief', which is distributed by Alcon L
Read more
19 Aug 24
Glenmark launches Olopatadine Hydrochloride Ophthalmic Solution
Glenmark Therapeutics Inc., USA (Glenmark) has launched Olopatadine Hydrochloride Ophthalmic Solutio
Read more
19 Aug 24